Annual Working Capital
$50.89 M
+$19.22 M+60.70%
December 31, 2023
Summary
- As of February 7, 2025, DMAC annual working capital is $50.89 million, with the most recent change of +$19.22 million (+60.70%) on December 31, 2023.
- During the last 3 years, DMAC annual working capital has risen by +$25.00 million (+96.54%).
- DMAC annual working capital is now at all-time high.
Performance
DMAC Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$46.47 M
-$5.46 M-10.51%
September 30, 2024
Summary
- As of February 7, 2025, DMAC quarterly working capital is $46.47 million, with the most recent change of -$5.46 million (-10.51%) on September 30, 2024.
- Over the past year, DMAC quarterly working capital has increased by +$754.00 thousand (+1.65%).
- DMAC quarterly working capital is now -10.51% below its all-time high of $51.93 million, reached on June 30, 2024.
Performance
DMAC Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
DMAC Working Capital Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +60.7% | +1.6% |
3 y3 years | +96.5% | -0.9% |
5 y5 years | +205.2% | -0.9% |
DMAC Working Capital Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +60.7% | -10.5% | +73.0% |
5 y | 5-year | at high | +576.9% | -10.5% | +518.1% |
alltime | all time | at high | +3392.7% | -10.5% | +3106.8% |
DiaMedica Therapeutics Working Capital History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $46.47 M(-10.5%) |
Jun 2024 | - | $51.93 M(+15.7%) |
Mar 2024 | - | $44.87 M(-11.8%) |
Dec 2023 | $50.89 M(+60.7%) | $50.89 M(+11.3%) |
Sep 2023 | - | $45.72 M(+16.4%) |
Jun 2023 | - | $39.28 M(+46.3%) |
Mar 2023 | - | $26.86 M(-15.2%) |
Dec 2022 | $31.67 M(-27.9%) | $31.67 M(-9.4%) |
Sep 2022 | - | $34.95 M(-7.1%) |
Jun 2022 | - | $37.64 M(-7.5%) |
Mar 2022 | - | $40.68 M(-7.4%) |
Dec 2021 | $43.91 M(+69.6%) | $43.91 M(-6.4%) |
Sep 2021 | - | $46.91 M(+132.4%) |
Jun 2021 | - | $20.19 M(-12.3%) |
Mar 2021 | - | $23.02 M(-11.1%) |
Dec 2020 | $25.89 M(+244.4%) | $25.89 M(-12.7%) |
Sep 2020 | - | $29.66 M(+165.3%) |
Jun 2020 | - | $11.18 M(-15.5%) |
Mar 2020 | - | $13.23 M(+76.0%) |
Dec 2019 | $7.52 M(-54.9%) | $7.52 M(-21.7%) |
Sep 2019 | - | $9.60 M(-15.3%) |
Jun 2019 | - | $11.33 M(-16.2%) |
Mar 2019 | - | $13.52 M(-18.9%) |
Dec 2018 | $16.68 M(+3296.3%) | $16.68 M(+360.5%) |
Sep 2018 | - | $3.62 M(-24.8%) |
Jun 2018 | - | $4.82 M(-25.5%) |
Mar 2018 | - | $6.46 M(+1216.2%) |
Dec 2017 | $491.00 K(-55.0%) | $491.00 K(+51.1%) |
Sep 2017 | - | $325.00 K(-64.6%) |
Jun 2017 | - | $917.20 K(-6894.1%) |
Mar 2017 | - | -$13.50 K(-101.2%) |
Dec 2016 | $1.09 M(-227.3%) | $1.09 M(-31.8%) |
Sep 2016 | - | $1.60 M(-251.8%) |
Jun 2016 | - | -$1.06 M(+71.6%) |
Mar 2016 | - | -$614.90 K(-28.3%) |
Dec 2015 | -$857.90 K | -$857.90 K(+22.3%) |
Sep 2015 | - | -$701.70 K(+925.9%) |
Date | Annual | Quarterly |
---|---|---|
Jun 2015 | - | -$68.40 K(-81.6%) |
Mar 2015 | - | -$372.60 K(-75.9%) |
Dec 2014 | -$1.55 M(-241.4%) | -$1.55 M(+112.6%) |
Sep 2014 | - | -$727.10 K(+217.4%) |
Jun 2014 | - | -$229.10 K(-66.9%) |
Mar 2014 | - | -$692.70 K(-163.4%) |
Dec 2013 | $1.09 M(+23.9%) | $1.09 M(+380.3%) |
Sep 2013 | - | $227.50 K(-83.0%) |
Jun 2013 | - | $1.33 M(-51.9%) |
Mar 2013 | - | $2.78 M(+214.7%) |
Dec 2012 | $882.10 K(-62.8%) | $882.10 K(-72.2%) |
Sep 2012 | - | $3.17 M(+1.9%) |
Jun 2012 | - | $3.11 M(+116.9%) |
Mar 2012 | - | $1.43 M(-39.5%) |
Dec 2011 | $2.37 M(-8.3%) | $2.37 M(-30.7%) |
Sep 2011 | - | $3.42 M(+161.2%) |
Jun 2011 | - | $1.31 M(-33.7%) |
Mar 2011 | - | $1.98 M(-23.6%) |
Dec 2010 | $2.59 M(+420.8%) | $2.59 M(+482.5%) |
Sep 2010 | - | $444.20 K(-62.2%) |
Jun 2010 | - | $1.17 M(+1366.8%) |
Mar 2010 | - | $80.10 K(-83.9%) |
Dec 2009 | $496.80 K(-78.6%) | $496.80 K(-50.3%) |
Sep 2009 | - | $1.00 M(-31.0%) |
Jun 2009 | - | $1.45 M(-13.2%) |
Mar 2009 | - | $1.67 M(-28.1%) |
Dec 2008 | $2.32 M(-31.2%) | $2.32 M(-23.3%) |
Sep 2008 | - | $3.03 M(+22.1%) |
Jun 2008 | - | $2.48 M(-20.0%) |
Mar 2008 | - | $3.10 M(-8.2%) |
Dec 2007 | $3.37 M(+1091.2%) | $3.37 M(-12.2%) |
Sep 2007 | - | $3.84 M(-3.3%) |
Jun 2007 | - | $3.97 M(-6.2%) |
Mar 2007 | - | $4.23 M(+1394.8%) |
Dec 2006 | $283.30 K(+8.2%) | $283.30 K(+62.3%) |
Sep 2006 | - | $174.50 K(-33.4%) |
Dec 2005 | $261.90 K(-121.0%) | $261.90 K |
Dec 2004 | -$1.25 M | - |
FAQ
- What is DiaMedica Therapeutics annual working capital?
- What is the all time high annual working capital for DiaMedica Therapeutics?
- What is DiaMedica Therapeutics annual working capital year-on-year change?
- What is DiaMedica Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for DiaMedica Therapeutics?
- What is DiaMedica Therapeutics quarterly working capital year-on-year change?
What is DiaMedica Therapeutics annual working capital?
The current annual working capital of DMAC is $50.89 M
What is the all time high annual working capital for DiaMedica Therapeutics?
DiaMedica Therapeutics all-time high annual working capital is $50.89 M
What is DiaMedica Therapeutics annual working capital year-on-year change?
Over the past year, DMAC annual working capital has changed by +$19.22 M (+60.70%)
What is DiaMedica Therapeutics quarterly working capital?
The current quarterly working capital of DMAC is $46.47 M
What is the all time high quarterly working capital for DiaMedica Therapeutics?
DiaMedica Therapeutics all-time high quarterly working capital is $51.93 M
What is DiaMedica Therapeutics quarterly working capital year-on-year change?
Over the past year, DMAC quarterly working capital has changed by +$754.00 K (+1.65%)